Calcium Chloride Injection, Solution
NDC Package 64253-900-91

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Calcium Chloride (calcium chloride injection) injection is 10% Calcium Chloride Injection, USP is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels. This formulation utilizes a injection, solution delivery system. Marketed by Medefil, Inc., this product is identified by NDC 64253-900 and is authorized under FDA application ANDA211553.

Identification & Billing

NDC Package Code
64253-900-91
Package Description
10 SYRINGE, PLASTIC in 1 BOX / 10 mL in 1 SYRINGE, PLASTIC
Product Code
64253-900
11-Digit Billing Format
64253090091
RxNorm Crosswalk
  • RxCUI: 828527 - calcium chloride 10 % in 10 ML Prefilled Syringe
  • RxCUI: 828527 - 10 ML calcium chloride 100 MG/ML Prefilled Syringe

Clinical Specifications

Proprietary Name
Calcium Chloride
Non-Proprietary Name
Calcium Chloride Injection
Substance Name
Calcium Chloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
CALCIUM CHLORIDE 100 mg/mL
Pharmacologic Class
Usage Information
10% Calcium Chloride Injection, USP is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels.

Regulatory & Marketing

Labeler Name
Medefil, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA211553
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-22-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J0618
Source: PDAC
INJECTION, CALCIUM CHLORIDE, 2 MG
HCPCS Dosage 2 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (64253-900). Click a package code to view its specific billing and regulatory data.

64253-900-36
60 SYRINGE, PLASTIC in 1 BOX / 10 mL in 1 SYRINGE, PLASTIC (64253-900-30)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64253-900-91 identifies a specific commercial package of 10 syringe, plastic in 1 box / 10 ml in 1 syringe, plastic of Calcium Chloride, a human prescription drug labeled by Medefil, Inc.. This injection, solution is formulated for intravenous use and contains calcium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medefil, Inc. on August 22, 2019. The current certification is valid through December 31, 2026.

How is this Medefil, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64253090091. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64253-900-91
11-Digit CMS (5-4-2)
64253-0900-91

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.